HTTP 200 verified twice
Finding your next stop…
Loading the latest directory information.
Loading the latest directory information.
Start here for the decision-making essentials: what Cognoa does, who it is for, how it is accessed, and the first-party sources behind this profile.
Canvas Dx is reimbursed by Highmark Insurance
Cognoa also secured Wyoming Medicaid covera
Cognoa is a pediatric behavioral health company whose FDA-authorized AI diagnostic, Canvas Dx, enables clinicians to diagnose or rule out autism in children ages 1.5 to 6 years via remote digital evaluation.
Read-only public captures of Cognoa’s homepage. Screenshots are dated, never live embeds, and open full-screen.
Short answers to the questions buyers and builders commonly ask about Cognoa. Each answer cites the shared ledger below, where every source is listed once.
Canvas Dx is the first and only FDA-authorized diagnostic solution designed to equip clini · AI & Machine Learning diagnostic support for early autism diagnosis
Canvas Dx is the first and only FDA authorized diagnostic solution designed to equip clinicians to diagnose or rule out autism in children ages 1.5 to 6 years – within days, not months or years.
Clinicians diagnosing or ruling out autism in children, and concerned parents and caregive · Clinicians diagnosing children ages 1.5 to 6 years
Whether you're a concerned parent or caregiver or a clinician, Cognoa's care team is here to help you successfully use Canvas Dx.
Remote, digital evaluation of children with developmental concerns to enable earlier autis · Diagnose or rule out autism
Remote, digital evaluation of children with developmental concerns overcomes long distances to scarce, oversubscribed specialty centers
Indicated for children ages 1.5 to 6 years only
children ages 1.5 to 6 years
Canvas Dx is reimbursed by Highmark Insurance; Cognoa also secured Wyoming Medicaid covera
Canvas Dx is now reimbursed by Highmark Insurance.
Canvas Dx is delivered as a remote, digital evaluation rather than an in-person specialty
Remote, digital evaluation of children with developmental concerns overcomes long distances to scarce, oversubscribed specialty centers
This profile connects the jobs Cognoa is described as handling with its delivery model, access options and the subjects used to match it to related products in this directory.
Each fact points to a recorded source, making it easy to distinguish verified product information from claims that need checking.
HTTP 200 verified twice
Home - Cognoa
Cognoa is an early childhood development and pediatric behavioral health company · Canvas Dx is the first and only FDA-authorized diagnostic solution · Diagnoses or rules out autism in children ages 1.5 to 6 years
Cognoa is an early childhood development and pediatric behavioral health company
Develop digital diagnostics and therapeutics to enable earlier and more equitable access to care that improves the lives and outcomes of children and families
Canvas Dx is the first and only FDA authorized diagnostic solution designed to equip clinicians to diagnose or rule out autism in children ages 1.5 to 6 years
Remote, digital evaluation of children with developmental concerns to enable earlier autism diagnosis
Clinicians diagnosing or ruling out autism in children, and concerned parents and caregivers
Digital diagnostics and therapeutics for pediatric behavioral health
Canvas Dx is delivered as a remote, digital evaluation rather than an in-person specialty clinic visit
Canvas Dx is reimbursed by Highmark Insurance; Cognoa also secured Wyoming Medicaid coverage as the first state Medicaid program to cover the diagnostic
Cognoa has launched state Medicaid program reimbursement for Canvas Dx, beginning with Wyoming
A concise view of the jobs, capabilities and integrations described in the recorded product sources.
Documented product formats, platforms and official distribution destinations. Availability can vary by region and plan.
A concise history of software releases and material product changes. Events appear only when a dated source supports what changed.
This profile is being checked for dated releases and material product changes. Nothing appears here until the exact date and event can be verified from a recorded source.
Facts, answers, structured details, milestones and primary resource links cite this shared ledger. Each external page appears once; release tags from the same GitHub project are grouped under one release history.
These tools share a workflow, capability or audience with Cognoa. They may complement it rather than replace it, and are not presented as integrations or endorsements.
Cognoa's care team provides direct support to clinicians, parents, and caregivers using Canvas Dx
Cognoa maintains official profiles on Facebook, X (@cognoainc), and LinkedIn (company/cognoa)
Early autism diagnosis and intervention for children, particularly underserved populations where specialty access is limited
Cognoa
Canvas Dx
AI & Machine Learning diagnostic support for early autism diagnosis
FDA authorized diagnostic system
Diagnose or rule out autism
Clinicians diagnosing children ages 1.5 to 6 years
FDA-authorized diagnostic medical device
United States (FDA)
Behavioral data from home videos and questionnaires used in autism detection studies
Canvas Dx received FDA authorization (post-2022 optimization published)
Indicated for children ages 1.5 to 6 years only
Cognoa is an early childhood development and pediatric behavioral health company · Legal entity is Cognoa, Inc. · Develops digital diagnostics and therapeutics
Cognoa
Cognoa, Inc.
Early childhood development and pediatric behavioral health company developing digital diagnostics and therapeutics
Enable earlier and more equitable access to care that improves the lives and outcomes of children and families
FDA-authorized diagnostic solution for autism
Remote, digital evaluation enabling clinicians to diagnose or rule out autism in children ages 1.5 to 6 years within days
Remote, digital evaluation
Responsible AI / AI and ML
Clinicians who diagnose autism in young children, and parents/caregivers of children with developmental concerns
Care team support for parents, caregivers, and clinicians using Canvas Dx
Early diagnosis and intervention for autism and developmental conditions in children
United States (FDA-authorized; first state Medicaid program in Wyoming; covered by Highmark Insurance)
https://www.facebook.com/cognoa, https://x.com/cognoainc, https://www.linkedin.com/company/cognoa
